Personal information
antimicrobial pharmacology, population pharmacokinetics, pharmacodynamics, mechniastic modeling, translational modeling, antibiotics, anti-infectives, beta-lactam antibiotics, aminoglycosides, cystic fibrosis, S-ADAPT
United States
Activities
Employment (6)
2020-07-01
to
present
|
Professor and Perry E. Foote Eminent Scholar Chair
(Department of Pharmacotherapy and Translational Research)
Employment
Source:
Jürgen Bulitta
2015-07-17
to
2020-06-30
|
Associate Professor, Pre-eminence Position in Drug Discovery & Development
(Department of Pharmacotherapy and Translational Research)
Employment
Source:
Jürgen Bulitta
2011-08-01
to
2015-04-15
|
Senior Research Fellow, ARC DECRA Fellow (2012-14), NHMRC Career Development Fellow (CDF level 2, 2015)
Employment
Source:
Jürgen Bulitta
2009-03-22
to
2011-07-15
|
Senior Scientist
Employment
Source:
Jürgen Bulitta
2006-08-15
to
2009-03-21
|
Postdoctoral fellow
(Pharmaceutical Sciences)
Employment
Source:
Jürgen Bulitta
1998-07-27
to
2007-08-09
|
Scientific co-worker
Employment
Source:
Jürgen Bulitta
Education and qualifications (2)
2003-11-01
to
2006-09-25
|
PhD in chemistry (Pharmcokinetics / Pharmacodynamics)
(Institute of Pharmacy & Food Chemistry)
Education
Source:
Jürgen Bulitta
1999-09-15
to
2003-10-03
|
MSc in Chemistry (German Diplom Degree)
Education
Source:
Jürgen Bulitta
Funding (21)
2018-08
to
2023-07
|
Grant
National Institute of Allergy and Infectious Diseases
(Bethesda, MD, US)
Source:
Jürgen Bulitta
2017-11
to
2022-10
|
Grant
National Institute of Allergy and Infectious Diseases
(Bethesda, MD, US)
Source:
Jürgen Bulitta
2017-09
to
2020-09
|
Contract
U.S. Food and Drug Administration
(MD, MD, US)
Source:
Jürgen Bulitta
2017-06
to
2019-05
|
Grant
University of Florida
(FL, FL, US)
GRANT_NUMBER:
DRPD-ROF2017
Source:
Jürgen Bulitta
Source:
Jürgen Bulitta
2017-01
to
2017-12
|
Grant
College of Pharmacy
(FL, FL, US)
GRANT_NUMBER:
COP PROSPER 2017
Source:
Jürgen Bulitta
Source:
Jürgen Bulitta
2016-09
to
2018-03
|
Contract
U.S. Food and Drug Administration
(MD, MD, US)
Source:
Jürgen Bulitta
2016-01-01
to
2018-01-01
|
Grant
National Health and Medical Research Council
(n/a, AU)
Source:
Jürgen Bulitta
via
DimensionsWizard
2015-01-01
to
present
|
Grant
National Health and Medical Research Council
(n/a, AU)
Source:
Jürgen Bulitta
via
DimensionsWizard
2015-01-01
to
2020-01-01
|
Grant
National Health and Medical Research Council
(n/a, AU)
Source:
Jürgen Bulitta
via
DimensionsWizard
2015-01-01
to
2017-12-31
|
Grant
Australian Research Council
(Canberra, AU)
Source:
Jürgen Bulitta
via
DimensionsWizard
2014-03
to
2019-02
|
Grant
National Institute of Allergy and Infectious Diseases
(MD, MD, US)
Source:
Jürgen Bulitta
2014-01-01
to
2017-12-31
|
Grant
Australian Research Council
(Canberra, AU)
Source:
Jürgen Bulitta
via
DimensionsWizard
2014-01-01
to
2017-01-01
|
Grant
National Health and Medical Research Council
(n/a, AU)
Source:
Jürgen Bulitta
via
DimensionsWizard
2014-01
to
2014-12
|
Grant
National Research Foundation of Korea
(Seoul, KR)
Source:
Jürgen Bulitta
2013-09
to
2017-11
|
Contract
U.S. Food and Drug Administration
(MD, MD, US)
GRANT_NUMBER:
HHSF223201310220C
Source:
Jürgen Bulitta
grade
Preferred source
(of
2)
2013-01-01
to
2016-01-01
|
Grant
National Health and Medical Research Council
(n/a, AU)
Source:
Jürgen Bulitta
via
DimensionsWizard
2013-01-01
to
2016-01-01
|
Grant
National Health and Medical Research Council
(n/a, AU)
Source:
Jürgen Bulitta
via
DimensionsWizard
2012-01-01
to
2014-12-31
|
Grant
Australian Research Council
(Canberra, AU)
Source:
Jürgen Bulitta
via
DimensionsWizard
2008-07
to
2012-06
|
Grant
National Institute of Allergy and Infectious Diseases
(MD, MD, US)
Source:
Jürgen Bulitta